Effect of zinc in treatment of Behcet syndrome

Phase 2

• Conditions: Behcet Syndrome.; Behcet's disease; M35.2

• Registration Number: IRCT20100606004105N30
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

Age range 18 to 50 years (premenopausal woman)
Diagnosis of Behcet's disease by a rheumatologist according to IBCD (The International Criteria for Behcet’s Disease) which vascular, eyes, and joints complications indicate the severity of the disease
Patients who want to participate in the study

Exclusion Criteria

Pregnancy and lactation
History of diabetes and other chronic diseases
History of other autoimmune diseases
Taking nutritional supplements and antioxidants and alpha lipoic acid during the month before the study

Study & Design

• Study Type: interventional
• Study Design: Not specified